To evaluate the efficacy of Buprenorphine and 2%lignocaine with adrenaline 1:80,000 when given as inferior alveolar nerve block in providing post- operative comfort after lower third molar surgery
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2019/08/021004
- Lead Sponsor
- Dr Sneha Punamiya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patient aged 18â??40 years requiring surgical removal of the impacted mandibular third molar
2)No significant medical history
Exclusion Criteria
1)Patient not willing to get enrolled in the study.
2)Patient with the known allergy to the drugs being used in the study.
3)Medically compromised Patients
4)patients who had consumed analgesics with in the 6 hrs prior to surgical procedure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Buprenorphine's analgesic synergy with 2% lignocaine in inferior alveolar nerve blocks?
How does Buprenorphine + 2% lignocaine with adrenaline compare to conventional local anesthetics in third molar surgery analgesia?
Which biomarkers correlate with prolonged post-operative pain relief from Buprenorphine-lignocaine nerve blocks in oral surgery?
What adverse events are reported with Buprenorphine-lignocaine combinations in dental nerve blocks and mitigation strategies?
Are there alternative opioid-anesthetic formulations for inferior alveolar nerve blocks in maxillofacial surgical recovery?